CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film...
CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
June 03, 2020 07:15 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of...
CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference
December 05, 2019 07:00 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD...
CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
October 09, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line...
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
October 01, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has appointed Dr. Vered Gigi as its chief scientific officer....